Table 2.

Baseline laboratory data

Laboratory tests	N	Mean±SD (normal range)
Carbohydrate metabolism
Fasting plasma glucose (mmol/L)	2827	5.6±1.4 (<5.5)
2-hour postprandial plasma glucose (mmol/L)	383	7.3±2.2 (<7.8)
Haemoglobin A1c (%)	843	6.1±1.4 (4.0–5.6)
Blood urea nitrogen (mmol/L)	1915	7.0±7.7 (2.5–7.1)
Serum creatinine (µmol/L)	1095	78.9±23.3 (60–110)
Lipid profile
Total cholesterol (mmol/L)	2786	6.3±1.2 (3.5–5.0)
High-density lipoprotein cholesterol (mmol/L)	1780	1.4±0.7 (0.9–1.5)
Low-density lipoprotein cholesterol (mmol/L)	1795	3.7±1.1 (<3.4)
Very-low-density lipoprotein cholesterol (mmol/L)	499	1.2±0.9 (0.1–1.7)
Serum triglyceride (mmol/L)	2080	2.1±0.9 (<1.7)
Liver function tests
Alanine aminotransferase (U/L)	2843	50.2±33.2 (M<41, F<33)
Aspartate aminotransferase (U/L)	2843	43.6±25.7 (M<50, F<35)
Gamma-glutamyl transferase (U/L)	2076	51.7±37.6 (M<49, F<32)
Alkaline phosphatase (U/L)	2076	137.4±80.7 (40–150)
Total bilirubin (µmol/L)	2588	17.5±9.0 (3–17)
Albumin (g/L)	990	47.3±12.8 (35–50)
Prothrombin activity (%)	1001	87.9±25.9 (70–100)
Gamma-globulin (g/L)	361	17.1±9.9 (7–16)
Serum iron (µmol/L)	939	18.5±5.8 (10–30)
Urine albumin (mg/L)	130	9.8±11.9 (<20)

N refers to the number of patients with adequate laboratory data.

F, female; M, male.